Home » Newsletters » BioWorld Science

BioWorld Science

May 28, 2009

View Archived Issues

Erythromycin shows efficacy in GERD in infants in clinical trial

ProMaxx formulation of inhaled insulin rapid and safe in healthy volunteers

Pregabalin may improve uremic pruritus in hemodialysis patients

Orchid Chemicals & Pharmaceuticals describes novel HDAC inhibitors as oncolytic compounds

Novel P2X3 receptor antagonists claimed by Merck & Co. as analgesics

Chugai and Gene Bridges expand license agreement for Red/ET recombineering technology

Gruenenthal describes novel progesterone receptor ligands as contraceptives

GlaxoSmithKline discovers novel chemokine CCR5 receptor antagonists for the treatment of HIV

Bristol-Myers Squibb claims glucocorticoid receptor modulators for the treatment of obesity

ACCOMPLISH trial shows benazepril regimens have same CV effect in kidney disease patients

ImmunoVaccine Technologies collaborates with FIT Biotech for HIV vaccine

Takeda licenses H. influenzae vaccine Vaxem Hib from Novartis

CEL-SCI initiates preclinical testing of treatment for swine flu and related H1N1 flu viruses

UCB launches Vimpat in the U.S. for add-on treatment of epilepsy in adults

Agennix presents update on clinical development of talactoferrin for RCC and NSCLC

XG-102 efficacious in mouse model of hemorrhagic stroke

ATHENA post-hoc analysis finds stroke risk reduction with dronedarone antiarrhythmic treatment

Vertex initiates phase III registration program for VX-770 in cystic fibrosis

Post hoc subanalysis of phase III trials reveals no age-dependent effects of epoetin zeta in CKD

FDA allows Medarex's IND application for phase I MDX-1338 trial

Fate Therapeutics treats first patient in phase Ib FT-1050 stem cell modulator trial

S-Nitrosoglutathione reductase inhibitor N30-6001 shows potential in experimental asthma

Clinical data on inhaled, intravenous alpha-1 antitrypsin from Kamada presented

CombinatoRx reports positive phase II results for CRx-401 in type 2 diabetes

Single doses of MEDI-528 do not affect allergen responses in asthma patients

FDA issues complete response letter to Allergan regarding sBLA for Botox for spasticity

Thomson Reuters makes Disease Briefing on influenza publicly available

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...